作者: Amos B. Smith , Setsuya Sasho , Bari A. Barwis , Paul Sprengeler , Joseph Barbosa
DOI: 10.1016/S0960-894X(98)00575-7
关键词:
摘要: A tetrahydropyran-based inhibitor (2) of mammalian ribonucleotide reductase (mRR) has been designed and synthesized based on the heptapeptide, N-AcFTLDADF (1), corresponding to C-terminus R2 subunit mRR. Inhibition studies revealed that 2 is indeed a competent inhibitor, albeit less potent than 1.